Conjunctivodacryocystorhinostomy (CDCR) with Lester Jones tube insertion was first described in 1962 for non-reconstructable lacrimal canalicular obstruction. 4 The lacrimal system is bypassed, and a Pyrex tube is introduced into the newly created passage between the medial conjunctival fornix and the lateral nasal wall. The standard CDCR described by Jones was an external procedure using a skin incision to create the bony osteotomy. In 2000, Trotter and Meyer 5 reported an endonasal approach demonstrating similar outcomes.
More recently Yung et al. have described an endoscopic technique (Ipswich procedure) where an initial endoscopic DCR is converted into a CDCR by forming a fistula from the medial conjunctival fornix, which is lined with a superiorly based septal flap. 6 Rather than healing by secondary intention as described by Jones, this confers the advantage of providing a mucosal lining to the fistula.
In this article, we describe our experience using Yung's modification of CDCR and describe the additional option a tubed flap based on the lateral nasal wall.
| Aim
The aim of this study was to review our CDCR patients' outcomes and to describe a simple modification of the Ipswich procedure.
| MATERIALS AND METHODS

| Ethical standards
The authors assert that all procedures contributing to this work com- 
| Surgical technique (modified Ipswich procedure)
The operation is performed under general anaesthetic in a hypotensive field. The nose is prepped with one of 1000 adrenaline patties placed into the middle meatus and local anaesthetic and adrenaline (Lignospan special, lidocaine 2% with 1 mg in one of 80 000 mL adrenaline) injected into the middle turbinate and lateral nasal wall.
An endoscopic DCR similar to that described by Wormald and Tsirbas 7 with extensive removal of bone is performed using 2-mm Kerrison bony rongeur and a DCR drill. This is converted to CDCR by excising the caruncle at the medial conjunctival fornix and using this wound to create a fistula from here through into the lateral wall of the lacrimal sac. This is performed under endoscopic guidance using a 3 mm gold Jones trocar. The fistula is stretched to a diameter of at least 4-5 mm using a pair of mosquito artery forceps. A superiorly based mucosal flap can either be sourced from the septum as described by Yung and Hardman-Lea 6 or as a long agger flap which
Keypoints
• Conjunctivodacryocystorhinostomy (CDCR) with Lester Jones tube insertion is performed for proximal nasolacrimal obstruction resistant to other treatments.
• CDCR is performed infrequently when compared with standard DCR and Quality evidence on the effectiveness of CDCR is lacking.
• A case series with objective and subjective outcome measures demonstrates good long-term success rates.
• A new adaptation using a tubed mucosal flap is described.
• CDCR is an effective treatment but has a higher complication rate than DCR the most common being tube extrusion.
F I G U R E 1 Creation of the long superiorly based agger lateral mucosal flap forms the right lateral nasal wall F I G U R E 2 Delivery of the mucosal flap through the rhinostomy to the medial canthus using a "pull-through" suture CORRESPONDENCE: OUR EXPERIENCE | 1397 is now our preference ( Figure 1 ). The flap is delivered through the rhinostomy to the medial canthus using a "pull-through" suture ( 
| RESULTS
A total of 11 eyes in 10 patients were treated with CDCR using the technique described above (one patient underwent bilateral surgery).
The mean age at operation was 44.6 years (Min=11, Max=67), with the mean age at PROMS being 55 years (Min=26, Max=72). There Table 1 . 
| DISCUSSION
The success rates of CDCR reported in literature and defined as resolution of symptoms vary from 57% to 100%. 9 Endonasal DCR is a successful intervention with demonstrable health benefits to the patients. Glasgow Benefit Inventory scores for standard DCR vary from 15.0 to 32.7.
8
Due to the small number of CDCR procedures carried out in most centres, the information available on success rates and complications is limited. The complication rate is generally higher than standard DCR, and includes tube extrusion (10%-82%), 9 tube obstruction and infection of the fistula. In our study, the objective success of the procedure by fluorescein appearance test was 91%, which is similar to the previously reported results. 9 Given, the primary aim of treatment is quality of life improvement, and the importance of assessing outcome using PROMS cannot be underestimated in lacrimal surgery. In this series, the patient benefit score by GBI (29.1) was also comparable with the results reported in the literature and with those for DCR surgery. As well as the GBI the Lac-Q questionnaire is useful and more specific for lacrimal surgery based on eyespecific and social impact scores. and the need for replacement in our cohort was rare with only one patient in the group requiring replacement so far and this was after 7 years of good symptom control.
The main limitations to our study design were the small sample size and the long period of patient recruitment during which our surgical technique underwent modifications. The answers to PROMS were collected at variable times following surgery and, therefore, some of them could be subject to recall bias. 
